Endothelial Monocyte Activating Polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis
- 20 July 2000
- journal article
- Published by Elsevier in Mechanisms of Development
- Vol. 95 (1-2) , 123-132
- https://doi.org/10.1016/s0925-4773(00)00361-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tissue interactions mediate early events in pulmonary vasculogenesisDevelopmental Dynamics, 2000
- Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial CellsThe Journal of Experimental Medicine, 1999
- Morphogenesis of the First Blood VesselsAnnals of the New York Academy of Sciences, 1998
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Overexpression of Vascular Endothelial Growth Factor in the Avian Embryo Induces Hypervascularization and Increased Vascular Permeability without Alterations of Embryonic Pattern FormationDevelopmental Biology, 1995
- Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.Proceedings of the National Academy of Sciences, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryoDevelopmental Biology, 1991
- Vasculogenesis and angiogenesis: Two distinct morphogenetic mechanisms establish embryonic vascular patternJournal of Experimental Zoology, 1989
- Epithelial-mesenchymal interaction during lung development: The effect of mesenchymal massDevelopmental Biology, 1976